Tevogen was (Nasdaq:TvgnThe stock jumped nearly 30% post-market after the company announced it was expanding its relationship with Microsoft (Nasdaq:Msft) to expand their AI-centric collaboration and deploy PredictCell technology for predictive precision T cell targeting.

Tevogen.ai will be an initiative